164 related articles for article (PubMed ID: 26705139)
1. Diffuse panbronchiolitis-The response and recurrence after erythromycin therapy.
Chuang MC; Chou YT; Lin YC; Hsieh MJ; Tsai YH
J Formos Med Assoc; 2016 Oct; 115(10):876-882. PubMed ID: 26705139
[TBL] [Abstract][Full Text] [Related]
2. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin.
Kudoh S; Azuma A; Yamamoto M; Izumi T; Ando M
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1829-32. PubMed ID: 9620913
[TBL] [Abstract][Full Text] [Related]
3. Idiopathic bronchiolitis mimicking diffuse panbronchiolitis.
Poletti V; Chilosi M; Trisolini R; Cancellieri A; Zompatori M; Lazzari Agli L; Boaron M; Schulte W; Theegarten D; Guzman J; Costabel U
Sarcoidosis Vasc Diffuse Lung Dis; 2003 Mar; 20(1):62-8. PubMed ID: 12737282
[TBL] [Abstract][Full Text] [Related]
4. [Diffuse panbronchiolitis: DPB].
Azuma A; Kudoh S
Nihon Rinsho; 1999 Sep; 57(9):2123-7. PubMed ID: 10497417
[TBL] [Abstract][Full Text] [Related]
5. Single center experience of five diffuse panbronchiolitis patients clinically presenting as severe asthma.
Park KH; Park HJ; Lee JH; Park JW
J Korean Med Sci; 2015 Jun; 30(6):823-8. PubMed ID: 26028938
[TBL] [Abstract][Full Text] [Related]
6. [Clinical effects of low-dose and long-term erythromycin in diffuse panbronchiolitis with chronic respiratory failure].
Ohno S; Sugiyama Y; Kitamura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Oct; 31(10):1251-6. PubMed ID: 8271657
[TBL] [Abstract][Full Text] [Related]
7. Diffuse panbronchiolitis, the first case reports in Thailand.
Chantarotorn S; Palwatwichai A; Vattanathum A; Tantamacharik D
J Med Assoc Thai; 1999 Aug; 82(8):833-8. PubMed ID: 10511794
[TBL] [Abstract][Full Text] [Related]
8. Macrolides for diffuse panbronchiolitis.
Lin X; Lu J; Yang M; Dong BR; Wu HM
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007716. PubMed ID: 25618845
[TBL] [Abstract][Full Text] [Related]
9. Macrolides for diffuse panbronchiolitis.
Yang M; Dong BR; Lu J; Lin X; Wu HM
Cochrane Database Syst Rev; 2013 Feb; (2):CD007716. PubMed ID: 23450579
[TBL] [Abstract][Full Text] [Related]
10. Effect of azithromycin on patients with diffuse panbronchiolitis: retrospective study of 51 cases.
Li H; Zhou Y; Fan F; Zhang Y; Li X; Yu H; Zhao L; Yi X; He G; Fujita J; Jiang D
Intern Med; 2011; 50(16):1663-9. PubMed ID: 21841323
[TBL] [Abstract][Full Text] [Related]
11. Centrilobular nodules correlate with air trapping in diffuse panbronchiolitis during erythromycin therapy.
Yamada G; Igarashi T; Itoh E; Tanaka H; Sekine K; Abe S
Chest; 2001 Jul; 120(1):198-202. PubMed ID: 11451838
[TBL] [Abstract][Full Text] [Related]
12. Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis.
Nagai H; Shishido H; Yoneda R; Yamaguchi E; Tamura A; Kurashima A
Respiration; 1991; 58(3-4):145-9. PubMed ID: 1745845
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of 32 cases of diffuse panbronchiolitis.
Zhang L; Ou Y; Hu H; Shen C; Cao Y; Chen Z; Ouyang R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):330-338. PubMed ID: 37164916
[TBL] [Abstract][Full Text] [Related]
14. [Long-term therapeutic effects of erythromycin and newquinolone antibacterial agents on diffuse panbronchiolitis].
Yamamoto M; Kondo A; Tamura M; Izumi T; Ina Y; Noda M
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Oct; 28(10):1305-13. PubMed ID: 2273658
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of peripheral lymphocyte subsets and changes due to erythromycin therapy in patients with diffuse panbronchiolitis].
Sugiyama Y; Sugama Y; Takeuchi K; Kudoh S; Kitamura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Dec; 28(12):1574-80. PubMed ID: 2077202
[TBL] [Abstract][Full Text] [Related]
16. [A mechanism of usefulness of treatment with erythromycin for diffuse panbronchiolitis].
Ichikawa Y; Ninomiya H; Koga H; Tokunaga N; Tanaka Y; Yano T; Oizumi K
Kansenshogaku Zasshi; 1991 Dec; 65(12):1501-7. PubMed ID: 1783799
[TBL] [Abstract][Full Text] [Related]
17. Azithromycin treats diffuse panbronchiolitis by targeting T cells via inhibition of mTOR pathway.
Weng D; Wu Q; Chen XQ; Du YK; Chen T; Li H; Tang DL; Li QH; Zhang Y; Lu LQ; Zhou NY; Song JC; Wang C; Li HP
Biomed Pharmacother; 2019 Feb; 110():440-448. PubMed ID: 30530046
[TBL] [Abstract][Full Text] [Related]
18. Diffuse panbronchiolitis: follow-up CT examination.
Akira M; Higashihara T; Sakatani M; Hara H
Radiology; 1993 Nov; 189(2):559-62. PubMed ID: 8210390
[TBL] [Abstract][Full Text] [Related]
19. Reversible airway lesions in diffuse panbronchiolitis. Detection by high-resolution computed tomography.
Ichikawa Y; Hotta M; Sumita S; Fujimoto K; Oizumi K
Chest; 1995 Jan; 107(1):120-5. PubMed ID: 7813262
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of cases allowed to cease erythromycin therapy for diffuse panbronchiolitis--comparative study between patients with cessation of the therapy and patients continuing the therapy].
Shirai R; Abe K; Yoshinaga M; Ishimatsu Y; Matsubara Y; Kawakami K; Iida K; Fujii T; Kawamoto S; Kaseda M; Kadota J; Kohno S
Kansenshogaku Zasshi; 1997 Nov; 71(11):1155-61. PubMed ID: 9455056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
